Literature DB >> 28528424

TRPS1 gene alterations in human subependymoma.

Sascha B Fischer1,2, Michelle Attenhofer1,2, Sakir H Gultekin3, Donald A Ross4,5, Karl Heinimann1,2.   

Abstract

Subependymoma is a rare primary brain tumor, constituting 0.07-0.51% of brain tumors. Genetic alterations in subependymoma are largely unknown, but familial occurrences have been reported. Trichorhinophalangeal syndrome type 1 (TRPS1) is a rare hereditary malformation complex caused by mutations in a gene identified in the year 2000 on 8q24.12. We report two patients with TRPS I and surgically treated subependymomas, one of whom has a first degree relative, now deceased, who was affected and also had a subependymoma. We therefore sought a role for the TRPS1 gene in the molecular oncogenesis of subependymoma. Formalin fixed tumor specimens and saliva samples were obtained from the two index patients as well as tumor samples from six sporadic subependymoma surgical specimens. A heterozygous TRPS1 germ line mutation predicted to cause a frame shift leading to a premature stop codon was found in the first index patient and also present in the associated tumor. No germline mutation was found in the second index patient, but his tumor displayed copy number neutral loss of heterozygosity in TRPS1. TRPS1 mutation analysis of the sporadic subependymomas revealed genetic, mostly loss of function alterations in one-third (two of six) of samples. Genetic alterations in TRPS1 likely play a role in at least a subgroup of subependymomas. Confirmation and further (epi)genetic investigations, ideally in newly acquired, fresh-frozen tumor samples, are warranted.

Entities:  

Keywords:  Mutation; Subependymoma; TRPS1; Trichorhinophalangeal syndrome type 1

Mesh:

Substances:

Year:  2017        PMID: 28528424     DOI: 10.1007/s11060-017-2496-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

1.  Simultaneous subependymomas in monozygotic female twins: further evidence for a common genetic or developmental disorder background.

Authors:  Susan Noell; Rudi Beschorner; Sotirios Bisdas; Ulrike Beyer; Ruthild G Weber; Petra Fallier-Becker; Rainer Ritz
Journal:  J Neurosurg       Date:  2014-03-21       Impact factor: 5.115

2.  The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer.

Authors:  Laszlo Radvanyi; Devender Singh-Sandhu; Scott Gallichan; Corey Lovitt; Artur Pedyczak; Gustavo Mallo; Kurt Gish; Kevin Kwok; Wedad Hanna; Judith Zubovits; Jane Armes; Deon Venter; Jalil Hakimi; Jean Shortreed; Melinda Donovan; Mark Parrington; Pamela Dunn; Ray Oomen; James Tartaglia; Neil L Berinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

3.  DNA-binding specificity of GATA family transcription factors.

Authors:  M Merika; S H Orkin
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III.

Authors:  H J Lüdecke; J Schaper; P Meinecke; P Momeni; S Gross; H Hirche; M J Abramowicz; B Albrecht; C Apacik; H J Christen; U Claussen; K Devriendt; E Fastnacht; A Forderer; U Friedrich; T H Goodship; M Greiwe; H Hamm; R C Hennekam; G K Hinkel; M Hoeltzenbein; H Kayserili; F Majewski; M Mathieu; R McLeod; A T Midro; U Moog; T Nagai; N Niikawa; K H Orstavik; E Plöchl; C Seitz; J Schmidtke; L Tranebjaerg; M Tsukahara; B Wittwer; B Zabel; G Gillessen-Kaesbach; B Horsthemke
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

5.  Phenotype and genotype in 103 patients with tricho-rhino-phalangeal syndrome.

Authors:  Saskia M Maas; Adam C Shaw; Hennie Bikker; Hermann-Josef Lüdecke; Karin van der Tuin; Magdalena Badura-Stronka; Elga Belligni; Elisa Biamino; Maria Teresa Bonati; Daniel R Carvalho; JanMaarten Cobben; Stella A de Man; Nicolette S Den Hollander; Nataliya Di Donato; Livia Garavelli; Sabine Grønborg; Johanna C Herkert; A Jeannette M Hoogeboom; Aleksander Jamsheer; Anna Latos-Bielenska; Anneke Maat-Kievit; Cinzia Magnani; Carlo Marcelis; Inge B Mathijssen; Maartje Nielsen; Ellen Otten; Lilian B Ousager; Jacek Pilch; Astrid Plomp; Gemma Poke; Anna Poluha; Renata Posmyk; Claudine Rieubland; Margharita Silengo; Marleen Simon; Elisabeth Steichen; Connie Stumpel; Katalin Szakszon; Edit Polonkai; Jenneke van den Ende; Antony van der Steen; Ton van Essen; Arie van Haeringen; Johanna M van Hagen; Joke B G M Verheij; Marcel M Mannens; Raoul C Hennekam
Journal:  Eur J Med Genet       Date:  2015-03-16       Impact factor: 2.708

Review 6.  Familial occurrence of subependymoma. Report of two cases.

Authors:  T C Ryken; R A Robinson; J C VanGilder
Journal:  J Neurosurg       Date:  1994-06       Impact factor: 5.115

7.  TRPS1 expression promotes angiogenesis and affects VEGFA expression in breast cancer.

Authors:  Jing Hu; Peng Su; Ming Jia; Xiaojuan Wu; Hui Zhang; Weiwei Li; Gengyin Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04

8.  A novel mutation in exon 7 in a family with mild tricho-rhino-phalangeal syndrome type I.

Authors:  M Gentile; P Fiorente; A L Buonadonna; F Macina; F Cariola
Journal:  Clin Genet       Date:  2003-02       Impact factor: 4.438

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  Increased expression of TRPS1 affects tumor progression and correlates with patients' prognosis of colon cancer.

Authors:  Jun Hong; Jie Sun; Tao Huang
Journal:  Biomed Res Int       Date:  2013-05-26       Impact factor: 3.411

View more
  2 in total

1.  Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience.

Authors:  Sung-Hye Park; Jae Kyung Won; Chi Heon Kim; Ji Hoon Phi; Seung-Ki Kim; Seung Hong Choi; Chun Kee Chung
Journal:  Neurospine       Date:  2022-09-30

2.  Clinical significance and biological function of transcriptional repressor GATA binding 1 in gastric cancer: a study based on data mining, RT-qPCR, immunochemistry, and vitro experiment.

Authors:  Hong Wu; Zhiguang Huang; Menglan Huang; Yiwu Dang; Huiping Lu; Xingan Qin; Liang Liang; Lihua Yang; Jie Ma; Gang Chen; Zili Lv
Journal:  Cell Cycle       Date:  2020-10-12       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.